CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
April 08, 2024 16:05 ET
|
Societal CDMO, Inc.; CoreRx, Inc.
CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract...
Global Pharmaceutical CDMO Market Analysis Report 2024-2030: AI-Assisted Drug Active Pharmaceutical Ingredient (API) Synthesis Gaining Attention
April 08, 2024 10:26 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial),...
Investigation into Avid Bioservices, Inc. Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know!
April 03, 2024 04:45 ET
|
Johnson Fistel, LLP
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Avid Bioservices, Inc.
Global Pharmaceutical CDMO Market to Soar with Projected Growth of 6.74% CAGR from 2024 to 2029
April 01, 2024 17:21 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization (CDMO) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts...
Global Small Molecule Innovator CDMO Market Forecasted to Reach USD 64.78 Billion by 2028
April 01, 2024 04:42 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
North America Topical Drugs CDMO Market Projected to Reach USD 26.45 Billion by 2030
April 01, 2024 04:37 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "North America Topical Drugs CDMO Market Size, Share & Trends Analysis Report by Product Type (Semi-Solid, Liquid), Service Type (Contract...
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
March 28, 2024 13:19 ET
|
Block & Leviton LLP
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Avid Bioservices, Inc. (NASDAQ: CDMO) for potential securities law violations. Investors who have lost money in their...
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
March 28, 2024 03:00 ET
|
Intravacc B.V.
Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravacc has IP and know-how in vaccine conjugation and manufacturing of carrier protein based...
SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
March 20, 2024 21:00 ET
|
Block & Leviton LLP
BOSTON, March 20, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Avid Bioservices, Inc. (NASDAQ: CDMO) for potential securities law violations. Investors who have lost money in their...
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
March 19, 2024 13:58 ET
|
CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS announces successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its Shanghai facility